WallStreetZenWallStreetZen

NASDAQ: FTH
Faeth Therapeutics Inc Stock Ownership - Who owns Faeth Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Faeth Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Cambrian Biopharma Inc10% Owner2026-06-01476$21.14
$10.06kSell
James Peyer10% Owner2026-06-01476$21.14
$10.06kSell
James Peyer10% Owner2026-06-0124,524$20.00
$490.48kSell
Cambrian Biopharma Inc10% Owner2026-06-0124,524$20.00
$490.48kSell
Millennium Management LLC10% Owner2026-04-07300$32.25
$9.67kSell
Millennium Management LLC10% Owner2026-04-074,423$31.38
$138.81kSell
Millennium Management LLC10% Owner2026-04-07205$29.72
$6.09kSell
Millennium Management LLC10% Owner2026-04-072,115$28.94
$61.21kSell
Millennium Management LLC10% Owner2026-04-071,108$33.38
$36.99kBuy
Millennium Management LLC10% Owner2026-04-071,108$33.38
$36.99kSell

1 of 8

FTH insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when FTH insiders and whales buy or sell their stock.

FTH Shareholders

What type of owners hold Faeth Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Hs Investments I LP329.82%4,425,998$64.31MInsider
Anand Kiran Parikh56.74%761,428$11.06MInsider
Vivo Capital LLC53.80%722,020$10.49MInstitution
Thomas G. Ricks51.09%685,632$9.96MInsider
Cormorant Asset Management LP22.82%306,222$4.45MInstitution
James Peyer21.26%285,284$4.15MInsider
Millennium Management LLC10.92%146,565$2.13MInstitution
Franklin Resources Inc9.95%133,506$1.94MInstitution
Stempoint Capital LP9.90%132,873$1.93MInstitution
Cambrian Biopharma Inc9.70%130,142$1.89MInsider

1 of 3

FTH vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
FTH23.79%76.21%Net SellingNet Selling
MRKR2.76%97.24%
PTN3.98%96.02%Net Selling
NRSN1.17%22.96%Net BuyingNet Buying
CELU2.18%97.82%Net SellingNet Selling
View Top Biotech Stocks

Faeth Therapeutics Stock Ownership FAQ

Who owns Faeth Therapeutics?

Faeth Therapeutics (NASDAQ: FTH) is owned by 160.70% institutional shareholders, 514.80% Faeth Therapeutics insiders, and 0.00% retail investors. Hs Investments I LP is the largest individual Faeth Therapeutics shareholder, owning 4.43M shares representing 329.82% of the company. Hs Investments I LP's Faeth Therapeutics shares are currently valued at $73.69M.

If you're new to stock investing, here's how to buy Faeth Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.